Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $6,914.3K | $9,360.3K | $12.9M | $14.1M | $19.3M | $29.4M | $21.0M | $27.3M | $62.3M | $68.2M | $63.5M | $83.5M | $104.5M | $141.2M | $194.0M | $270.2M | $366.3M | $670.5M | $801.5M | $632.4M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Repligen Corporation's last 12-month Revenue is $616.0M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Repligen Corporation's Revenue growth was (8.0%). The average annual Revenue growth rates for Repligen Corporation have been 12.5% over the past three years, 19.5% over the past five years.
Over the last year, Repligen Corporation's Revenue growth was (8.0%), which is lower than industry growth of 0.0%. It indicates that Repligen Corporation's Revenue growth is Bad.